Pipeline


Drug Candidates in Research & Development & Other Product Candidates; CVBT has three open INDs with the US FDA and one active preclinical program.  They are each discussed below.

FDA Authorized Clinical Trials:

Drug Candidate

 

Indication

•   CVBT-141B

 

Chronic Diabetic Foot Ulcers (Wound Healing)

•   CVBT-141C

 

Peripheral Arterial Disease (“PAD”)

•   CVBT-141H

 

Severe Coronary Heart Disease (“CHD”) – injection catheter delivery

Pre-Clinical Research and Development:

Drug Candidate

 

Indication

•   CVBT-141D

 

Ischemic Disc Disease



Use of this site constitutes agreement to our Terms and Conditions and Privacy Policy.
Some content on this site requires the free Adobe Reader.
©2015 CardioVascular BioTherapeutics, Inc.